Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression.

Bournazos S, Grinfeld J, Alexander KM, Murchison JT, Wallace WA, McFarlane P, Hirani N, Simpson AJ, Dransfield I, Hart SP.

BMC Pulm Med. 2010 Oct 7;10:51. doi: 10.1186/1471-2466-10-51.

2.

Fcγ receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis.

Bournazos S, Bournazou I, Murchison JT, Wallace WA, McFarlane P, Hirani N, Simpson AJ, Dransfield I, Hart SP.

Lung. 2010 Dec;188(6):475-81. doi: 10.1007/s00408-010-9262-3. Epub 2010 Oct 6.

PMID:
20924590
3.

[Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].

Yuan YD, Zhao MX, Yu J.

Zhonghua Jie He He Hu Xi Za Zhi. 2011 Nov;34(11):841-5. Chinese.

PMID:
22333472
4.

Association of Fcgamma receptor IIa genotype with chronic periodontitis in Caucasians.

Yamamoto K, Kobayashi T, Grossi S, Ho AW, Genco RJ, Yoshie H, De Nardin E.

J Periodontol. 2004 Apr;75(4):517-22.

PMID:
15152814
5.

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.

Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, Russell AM, Denton CP, Abraham DJ, Hansell DM, Nicholson AG, Maher TM, Wells AU, Lindahl GE, Renzoni EA.

Thorax. 2013 May;68(5):436-41. doi: 10.1136/thoraxjnl-2012-201786. Epub 2013 Jan 15.

PMID:
23321605
6.

[Association of ENA-78, IP-10 and VEGF gene polymorphism with idiopathic pulmonary fibrosis].

Liu L, Dai HP, Xiao B, Zhang S, Ban CJ, Xin P.

Zhonghua Yi Xue Za Zhi. 2009 Oct 20;89(38):2690-4. Chinese.

PMID:
20137269
7.

MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis.

Checa M, Ruiz V, Montaño M, Velázquez-Cruz R, Selman M, Pardo A.

Hum Genet. 2008 Dec;124(5):465-72. doi: 10.1007/s00439-008-0571-z. Epub 2008 Oct 14.

PMID:
18853190
8.

Copy number variation of FCGR3B is associated with susceptibility to idiopathic pulmonary fibrosis.

Bournazos S, Bournazou I, Murchison JT, Wallace WA, McFarlane P, Hirani N, Simpson AJ, Dransfield I, Hart SP.

Respiration. 2011;81(2):142-9. doi: 10.1159/000321997. Epub 2010 Nov 27.

PMID:
21109729
9.

TGF-β1 T869C polymorphism may affect susceptibility to idiopathic pulmonary fibrosis and disease severity.

Son JY, Kim SY, Cho SH, Shim HS, Jung JY, Kim EY, Lim JE, Park BH, Kang YA, Kim YS, Kim SK, Chang J, Park MS.

Lung. 2013 Apr;191(2):199-205. doi: 10.1007/s00408-012-9447-z. Epub 2013 Jan 24.

PMID:
23344525
10.

Association of the SNP rs1800925(C/T) in the interleukin-13 gene promoter with pulmonary function in Chinese Han patients with idiopathic pulmonary fibrosis.

Ding M, Sheng H, Shen W, Zhen J, Xi L, Zeng J, Zhang Y, Wu D, Deng L.

Cell Biochem Biophys. 2013;67(3):905-9. doi: 10.1007/s12013-013-9580-1.

PMID:
23549736
11.

A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode.

Ahn MH, Park BL, Lee SH, Park SW, Park JS, Kim DJ, Jang AS, Park JS, Shin HK, Uh ST, Kim YK, Kim YW, Han SK, Jung KS, Lee KY, Jeong SH, Park JW, Choi BW, Park IW, Chung MP, Shin HD, Song JW, Kim DS, Park CS, Shim YS.

Respir Res. 2011 Jun 8;12:73. doi: 10.1186/1465-9921-12-73.

12.

Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression.

Molina-Molina M, Xaubet A, Li X, Abdul-Hafez A, Friderici K, Jernigan K, Fu W, Ding Q, Pereda J, Serrano-Mollar A, Casanova A, Rodríguez-Becerra E, Morell F, Ancochea J, Picado C, Uhal BD.

Eur Respir J. 2008 Oct;32(4):1004-8. doi: 10.1183/09031936.00015808. Epub 2008 May 28.

13.

Differences in Fcgamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali.

Israelsson E, Vafa M, Maiga B, Lysén A, Iriemenam NC, Dolo A, Doumbo OK, Troye-Blomberg M, Berzins K.

Malar J. 2008 Sep 15;7:175. doi: 10.1186/1475-2875-7-175.

14.

Fcgamma receptor polymorphisms in relation to periodontitis.

Loos BG, Leppers-Van de Straat FG, Van de Winkel JG, Van der Velden U.

J Clin Periodontol. 2003 Jul;30(7):595-602.

PMID:
12834496
15.

FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients.

Yun HR, Koh HK, Kim SS, Chung WT, Kim DW, Hong KP, Song GG, Chang HK, Choe JY, Bae SC, Salmon JE, Yoo DH, Kim TY, Kim SY.

Lupus. 2001;10(7):466-72.

PMID:
11480843
16.

FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan.

Nasr A, Iriemenam NC, Giha HA, Balogun HA, Anders RF, Troye-Blomberg M, ElGhazali G, Berzins K.

Malar J. 2009 Mar 13;8:43. doi: 10.1186/1475-2875-8-43.

17.

Analysis of Fcgamma receptor IIa (cd32) gene polymorphism and anti-malarial IgG subclass antibodies to asexual blood-stage antigen of Plasmodium falciparum in an unstable malaria endemic area of Iran.

Zakeri S, Mashhadi R, Mehrizi AA, Djadid ND.

Exp Parasitol. 2013 May;134(1):115-21. doi: 10.1016/j.exppara.2013.02.012. Epub 2013 Feb 28.

PMID:
23458236
18.

Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment.

Kondoh Y, Taniguchi H, Ogura T, Johkoh T, Fujimoto K, Sumikawa H, Kataoka K, Baba T, Colby TV, Kitaichi M.

Respirology. 2013 Jul;18(5):820-6. doi: 10.1111/resp.12082.

PMID:
23489318
19.

The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.

O'Dwyer DN, Armstrong ME, Trujillo G, Cooke G, Keane MP, Fallon PG, Simpson AJ, Millar AB, McGrath EE, Whyte MK, Hirani N, Hogaboam CM, Donnelly SC.

Am J Respir Crit Care Med. 2013 Dec 15;188(12):1442-50. doi: 10.1164/rccm.201304-0760OC.

PMID:
24070541
20.

FcγRIIa polymorphism and anti-malaria-specific IgG and IgG subclass responses in populations differing in susceptibility to malaria in Burkina Faso.

Cherif MK, Sanou GS, Maiga B, Israelsson E, Ouédraogo AL, Bougouma EC, Diarra A, Ouédraogo A, Ouattara AS, Troye-Blomberg M, Dolo A, Cavanagh DR, Theisen M, Modiano D, Sirima SB, Nebié I.

Scand J Immunol. 2012 Jun;75(6):606-13. doi: 10.1111/j.1365-3083.2012.02690.x.

Items per page

Supplemental Content

Write to the Help Desk